Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 11727661

Engineering data exchange.

M Moore
View original source ↗Export metadata ↓

Abstract

UNLABELLED: Mount Clemens General Hospsital, Mount Clemens, Mich. PROBLEM: performance anomalies due to multiple interfaces with separate systems. SOLUTION: implementation of an interface engine. RESULTS: improved management of data exchange among disparate systems. KEYS TO SUCCESS: up-front studies of vendor offerings, potential problems, and long-term needs.

Explore related subjects

Capital ExpendituresComputer Communication NetworksHospital Bed Capacity, 100 to 299Hospital Information SystemsHospitals, OsteopathicHospitals, TeachingMichiganOrganizational Case StudiesSystems IntegrationJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Moore. 2001. Engineering data exchange.. https://pubmed.ncbi.nlm.nih.gov/11727661/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

The price of innovation: new estimates of drug development costs.

The research and development costs of 68 randomly selected new drugs were obtained from a survey of 10 pharmaceutical firms. These data were used to estimate the average pre-tax cost of new drug development. The costs of compounds abandoned during testing were linked to the costs of compounds that obtained marketing approval. The estimated average out-of-pocket cost per new drug is 403 million US dollars (2000 dollars). Capitalizing out-of-pocket costs to the point of marketing approval at a real discount rate of 11% yields a total pre-approval cost estimate of 802 million US dollars (2000 dollars). When compared to the results of an earlier study with a similar methodology, total capitalized costs were shown to have increased at an annual rate of 7.4% above general price inflation.

Capital Expenditures↗
PubMed2003

Evaluating group purchasing organizations.

A formal evaluation process can help healthcare organizations assess the current and/or potential value of a group purchasing organization (GPO). Healthcare organizations should approach a GPO evaluation as if they were entering into a new relationship. The evaluation should include purchasing and financial services, value-added services, and corporate relations/business practices. Healthcare organizations should consider the potential economies of scale and other services offered by a GPO. Healthcare organizations should consider using acceptable substitutes for products currently used or seeking products through alternative sources if doing so achieves greater value.

Capital Expenditures↗